NCT01297712

Brief Summary

Polyps found during screening colonoscopy have to be removed or at least biopsied. Attempts to save costs include endoscopic assessment of polyps with regards to differential diagnoses between adenomas (which have to be removed) and hyperplastic polyps (could be left in place or removed and not examined histologically). Such a concept would only be feasible if endoscopy can make the differential diagnosis with high accuracy. Such high accuracy rates - between 80% and 95% - have been reported from reference centers with specific scientific interest. The investigators want to test whether these results a) can be reproduced in the private practice setting performing large-volume screening colonoscopies and b) whether latest generation endoscopes provide benefit in terms of better accuracy.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,069

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2009

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2009

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2010

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

February 14, 2011

Completed
3 days until next milestone

First Posted

Study publicly available on registry

February 17, 2011

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2011

Completed
Last Updated

June 7, 2019

Status Verified

April 1, 2019

Enrollment Period

1.2 years

First QC Date

February 14, 2011

Last Update Submit

June 5, 2019

Conditions

Keywords

screening colonoscopyadenomahyperplastic polypdifferential diagnosis

Outcome Measures

Primary Outcomes (1)

  • Accuracy (sensitivity/specificity) of HDTV/iScan image technology (Hi Line) versus conventional colonoscopy (classic Line) in the diagnosis of adenomas versus hyperplastic polyps

    14 months

Secondary Outcomes (1)

  • Comparison of online accuracy during colonoscopy with later blinded image assessment in the differential diagnosis of adenomas versus hyperplastic polyps

    14 months

Study Arms (2)

Hi Line

ACTIVE COMPARATOR

This arm is examined with latest generation HDTV colonoscopes

Device: Latest generation colonoscopy as diagnostic instrument

Classic Line

NO INTERVENTION

control group undergoing colonoscopy with older generation scope currently in use in most centers

Interventions

this endoscope is used as compared to an older generations cope (classic line) currently in use

Also known as: Hi Line colonoscopy, IScan Colonoscope
Hi Line

Eligibility Criteria

Age55 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All patients undergoing screening colonoscopy

You may not qualify if:

  • Missing consent
  • No screening colonoscopy (diagnostic colonoscopy because of symptoms)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Hamburg-Eppendorf

Hamburg, 22453, Germany

Location

Related Publications (1)

  • Schachschal G, Mayr M, Treszl A, Balzer K, Wegscheider K, Aschenbeck J, Aminalai A, Drossel R, Schroder A, Scheel M, Bothe CH, Bruhn JP, Burmeister W, Stange G, Bahr C, Kiesslich R, Rosch T. Endoscopic versus histological characterisation of polyps during screening colonoscopy. Gut. 2014 Mar;63(3):458-65. doi: 10.1136/gutjnl-2013-304562. Epub 2013 Jun 28.

MeSH Terms

Conditions

Colonic PolypsAdenoma

Condition Hierarchy (Ancestors)

Intestinal PolypsPolypsPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsNeoplasms, Glandular and EpithelialNeoplasms by Histologic TypeNeoplasms

Study Officials

  • Thomas Rösch, MD

    Universitätsklinikum Hamburg-Eppendorf

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director

Study Record Dates

First Submitted

February 14, 2011

First Posted

February 17, 2011

Study Start

September 1, 2009

Primary Completion

November 1, 2010

Study Completion

April 1, 2011

Last Updated

June 7, 2019

Record last verified: 2019-04

Locations